Population included at the beginning of ECMO support
transcatheter aortic valve, COPD
CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COPD, VENTILATOR-ASSOCIATED PNEUMONIA
Between January 1, 2016, and December 31, 2019, 239 patients were included in the study, among whom 65 received levosimendan (flowchart, Fig. Flow diagram of the population included at the beginning of ECMO supportDescription of the population included at the beginning of ECMO supportBMI, body mass index; CABG, coronary artery bypass graft; CPB, cardiopulmonary bypass; COPD, chronic obstructive pulmonary disease; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump; LVAD, left ventricular assist device; NA, not available (missing data); Q1, first quartile; Q3, third quartile; RBC, red blood cells; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment; TAVI, transcatheter aortic valve implantation; VAP, ventilator-associated pneumonia; VIS, vasoactive inotropic score. For covariates which the median was null in both groups, they were described with their mean and standard deviation